Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
43
ATGE Quote, Financials, Valuation and Earnings
Last price:
$116.62
Seasonality move
:
-2.01%
Day range:
$114.94 - $118.94
52-week range:
$67.30 - $140.12
Dividend yield:
0%
P/E ratio:
19.40x
P/S ratio:
2.58x
P/B ratio:
2.92x
Volume:
449.4K
Avg. volume:
432.7K
1-year change:
50.84%
Market cap:
$4.2B
Revenue:
$1.6B
EPS (TTM):
$6.00
Analysts' Opinion
-
Consensus RatingAdtalem Global Education has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $143.25, Adtalem Global Education has an estimated upside of 22.94% from its current price of $116.52.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $140.00 representing 100% downside risk from its current price of $116.52.
Fair Value
-
According to the consensus of 3 analysts, Adtalem Global Education has 22.94% upside to fair value with a price target of $143.25 per share.
ATGE vs. S&P 500
-
Over the past 5 trading days, Adtalem Global Education has underperformed the S&P 500 by -3.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Adtalem Global Education does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Adtalem Global Education has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Adtalem Global Education reported revenues of $466.1M.
Earnings Growth
-
Adtalem Global Education has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Adtalem Global Education reported earnings per share of $1.59.
Enterprise value:
4.6B
EV / Invested capital:
--
Price / LTM sales:
2.58x
EV / EBIT:
13.70x
EV / Revenue:
2.62x
PEG ratio (5yr expected):
0.16x
EV / Free cash flow:
15.72x
Price / Operating cash flow:
15.46x
Enterprise value / EBITDA:
10.81x
Gross Profit (TTM):
$986.1M
Return On Assets:
8.42%
Net Income Margin (TTM):
13.34%
Return On Equity:
16.71%
Return On Invested Capital:
11.5%
Operating Margin:
19.53%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.4B | $1.5B | $1.7B | $412.7M | $466.1M | |
| Gross Profit | $800.8M | $859.7M | $986.1M | $237.3M | $266.2M | |
| Operating Income | $235M | $228M | $340.3M | $80.6M | $91M | |
| EBITDA | $326.8M | $307.7M | $422.4M | $88.1M | $115M | |
| Diluted EPS | $1.72 | $2.67 | $6.00 | $0.93 | $1.59 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.5B | $1B | $533M | $387.6M | $450.3M | |
| Total Assets | $3B | $3.5B | $2.9B | $2.7B | $2.8B | |
| Current Liabilities | $382.2M | $521.2M | $437.9M | $509.1M | $540.6M | |
| Total Liabilities | $1.7B | $2B | $1.4B | $1.4B | $1.4B | |
| Total Equity | $1.3B | $1.5B | $1.5B | $1.3B | $1.4B | |
| Total Debt | $1.1B | $1.2B | $694.4M | $648.1M | $552.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $108.2M | $278M | $338.5M | $153.6M | $207.9M | |
| Cash From Investing | $20.2M | -$39.1M | -$45.9M | -$12.7M | -$10M | |
| Cash From Financing | -$602.4M | -$368.7M | -$258.7M | -$139.7M | -$172.1M | |
| Free Cash Flow | $80.3M | $238.7M | $290.6M | $140.9M | $197.7M | |
ATGE
Sector
Market Cap
$4.2B
$426.2M
Price % of 52-Week High
83.16%
73.88%
Dividend Yield
0%
0%
Shareholder Yield
5.08%
4%
1-Year Price Total Return
50.84%
-11.07%
Beta (5-Year)
0.900
0.767
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$119.01
200-day SMA
Buy
Level
$100.90
Bollinger Bands (100)
Buy
Level
100.37 - 126.21
Chaikin Money Flow
Buy
Level
108M
20-day SMA
Sell
Level
$122.62
Relative Strength Index (RSI14)
Sell
Level
37.46
ADX Line
Sell
Level
18.93
Williams %R
Buy
Level
-89.7511
50-day SMA
Sell
Level
$125.09
MACD (12, 26)
Sell
Level
-1.76
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
50.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.2314)
Buy
CA Score
(Annual)
Level (0.1548)
Buy
Beneish M-Score
(Annual)
Level (-2.5201)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-0.2596)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.
Stock Forecast FAQ
In the current month, ATGE has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ATGE average analyst price target in the past 3 months is $143.25.
-
Where Will Adtalem Global Education Stock Be In 1 Year?
According to analysts, the consensus estimate is that Adtalem Global Education share price will rise to $143.25 per share over the next 12 months.
-
What Do Analysts Say About Adtalem Global Education?
Analysts are divided on their view about Adtalem Global Education share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Adtalem Global Education is a Sell and believe this share price will drop from its current level to $140.00.
-
What Is Adtalem Global Education's Price Target?
The price target for Adtalem Global Education over the next 1-year time period is forecast to be $143.25 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ATGE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Adtalem Global Education is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ATGE?
You can purchase shares of Adtalem Global Education via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Adtalem Global Education shares.
-
What Is The Adtalem Global Education Share Price Today?
Adtalem Global Education was last trading at $116.62 per share. This represents the most recent stock quote for Adtalem Global Education. Yesterday, Adtalem Global Education closed at $116.52 per share.
-
How To Buy Adtalem Global Education Stock Online?
In order to purchase Adtalem Global Education stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
